"Coastal Pediatric Research started in the spring of 2012 as an extension of Coastal Pediatric Associates (CPA). Our research enterprise has grown into a multi-specialty, diverse pediatric research program within our private practice setting. Our purpose is to nurture and champion the health of all children and their families, and we are proud to be compassionate, relentless advocates for all within our charge. We succeed by guaranteeing children access to a medical home – embracing industry trends and innovations that have a positive impact on the community while deliberately making business decisions that lead to growth and strategic partnerships."

During the past decade, Coastal Pediatric Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coastal Pediatric Research" #1 sponsor was "Pfizer" with 5 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Pediatric Research" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Coastal Pediatric Research" are "Respiratory Tract Infection" (2 trials), "COVID-19" (1 trials), "Group B Streptococcus Infections" (1 trials), "Growth" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Coastal Pediatric Research" in a lesser frequency.

Most popular intervention types in "Coastal Pediatric Research" are "Biological" (8 trials), "Other" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "BNT162b2 20mcg" (1 trials) and "BNT162b2 30mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Coastal Pediatric Research" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Coastal Pediatric Research". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Coastal Pediatric Research, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Coastal Pediatric Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".